Valuation: Primary Health Care Limited

Market Cap 385M 266M 237M 218M 198M 376M 24.92B 2.61B 1.04B 13.34B 998M 976M 42.01B P/E 2027 *
98.1x
P/E 2028 * -112x
Enterprise Value 1.16B 802M 716M 659M 598M 1.13B 75.21B 7.88B 3.14B 40.26B 3.01B 2.95B 127B EV / Sales 2027 *
0.84x
EV / Sales 2028 * 0.82x
Free-Float
77.69%
Yield 2027 *
-
Yield 2028 * 1.48%

Last Transcript: Primary Health Care Limited

Manager TitleAgeSince
Chief Executive Officer - 05/03/2024
Director of Finance/CFO - 13/10/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 21/08/2018
Chairman 65 28/11/2023
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-3.02%+1.58% - - 261M
+2.35%-4.93%+12.07%+28.40% 109B
+0.13%+9.07%+9.91%+116.83% 105B
-1.45%-18.98%+52.39%+573.68% 46.46B
+1.47%+8.03%+10.16%+105.72% 33.1B
-0.31%+4.58%+41.75%+80.75% 30.19B
-0.59%+4.34%+39.87%+94.09% 28.57B
+0.70%+8.78%+49.02%+439.34% 23B
+0.23%+1.42%-17.61%-15.87% 19.97B
+0.52%-1.40%-6.52%+30.30% 16.76B
Average -0.00%+1.30%+21.23%+161.47% 46B
Weighted average by Cap. +0.60%+0.94%+19.87%+147.83%

Financials

2027 *2028 *
Net sales 1.39B 958M 855M 787M 714M 1.35B 89.79B 9.41B 3.75B 48.07B 3.6B 3.52B 151B 1.41B 977M 872M 803M 728M 1.38B 91.59B 9.6B 3.83B 49.03B 3.67B 3.59B 154B
Net income -2.77M -1.91M -1.71M -1.57M -1.42M -2.7M -179M -18.77M -7.48M -95.86M -7.17M -7.02M -302M -4.35M -3M -2.68M -2.47M -2.24M -4.24M -281M -29.49M -11.75M -151M -11.27M -11.03M -474M
Net Debt 777M 537M 479M 441M 400M 758M 50.29B 5.27B 2.1B 26.92B 2.01B 1.97B 84.8B 776M 536M 479M 440M 400M 758M 50.27B 5.27B 2.1B 26.91B 2.01B 1.97B 84.76B
Logo Primary Health Care Limited
Healius Limited is a healthcare company. The Company's specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include Abbot, Agilex Biolabs, Dorevitch, Gastrolab, Genomic Diagnostics, IQ Pathology, Kossard Dermatopathology, Laverty Pathology, QML Pathology, TML Pathology, Vetnostics Pathology and Western Diagnostic Pathology (WDP). These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Primary Health Care Limited